Patents by Inventor Jose de Jesus de la Fuente Garcia

Jose de Jesus de la Fuente Garcia has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of E. coli strains expressing high level of alpha-Gal to modulate immunity and provide protection against infectious diseases in animals
    Publication number: 20230232882
    Abstract: The present invention concerns an E. coli strains expressing high level of ?-Gal, in particular selected in the group consisting of E. coli Nissle 1917 strain, E. coli O111 strain, E. coli O86:B7 strain, and mixture thereof, as a probiotic and/or feed additive and/or oral vaccine in a non-human animal, in particular fish and poultry, to prevent and/or reduce an infectious disease caused by a pathogen expressing ?-Gal on its surface.
    Type: Application
    Filed: June 3, 2021
    Publication date: July 27, 2023
    Inventors: Alejandro CABEZAS-CRUZ, Lourdes MATEOS-HERNANDEZ, Astrid Sibylle HOLZER, Luis BERMUDEZ-HUMARAN, Veronica RISCO-CASTILLO, Jose de Jesus DE LA FUENTE-GARCIA, Edgar TORRES-MARAVILLA, Jacques GUILLOT
  • Sea Lice Vaccine
    Publication number: 20220265790
    Abstract: The present invention describes vaccine compositions for treatment and/or prevention against sea lice infestation in salmon. The present invention further describes nucleic acids, host cells, vectors and methods of using said vaccine for the prevention and/or treatment of sea lice infestation in salmon.
    Type: Application
    Filed: October 1, 2021
    Publication date: August 25, 2022
    Inventors: Jose de Jesus de la Fuente Garcia, Marinela Contreras Rojo, Margarita Maria Villar Rayo, Marius Andre De Feijter Karlsen, Bjorn Erik Brudeseth, Karine Lindmo Yttredal, Christer Ross Wiik-Nielsen, Rolf Hetlelid Olsen, Liv Blom Hungerholdt
  • IMMUNOSTIMULANT FOR USE AGAINST PATHOGENS
    Publication number: 20220054557
    Abstract: The present invention relates to compositions comprising an inactivated Mycobacterium or an immunogenic fraction thereof, for use in the prevention of an infection in a subject, wherein the infection is selected from the group consisting of a protozoan parasitic infection and a bacterial infection, with the proviso that the infection is not caused by a Mycobacterium.
    Type: Application
    Filed: December 4, 2019
    Publication date: February 24, 2022
    Inventors: Ramón Antonio JUSTE JORDÁN, Lucas DOMINGUEZ RODRIGUEZ, Christian GORTÁZAR SCHMIDT, José de Jesus DE LA FUENTE GARCÍA, Joseba M. GARRIDO URKULLU, Iker AGIRREGOMOSKORTA SEVILLA, Mercedes DOMINGUEZ RODRIGUEZ
  • Sea lice vaccine
    Patent number: 11167017
    Abstract: The present invention describes vaccine compositions for treatment and/or prevention against sea lice infestation in salmon. The present invention further describes nucleic acids, host cells, vectors and methods of using said vaccine for the prevention and/or treatment of sea lice infestation in salmon.
    Type: Grant
    Filed: August 16, 2017
    Date of Patent: November 9, 2021
    Assignee: Pharmaq AS
    Inventors: Jose de Jesus de la Fuente Garcia, Marinela Contreras Rojo, Margarita Maria Villar Rayo, Marius Andre De Feijter Karlsen, Bjorn Erik Brudeseth, Karine Lindmo Yttredal, Christer Ross Wiik-Nielsen, Rolf Hetlelid Olsen, Liv Blom Hungerholdt
  • Sea Lice Vaccine
    Publication number: 20190167772
    Abstract: The present invention describes vaccine compositions for treatment and/or prevention against sea lice infestation in salmon. The present invention further describes nucleic acids, host cells, vectors and methods of using said vaccine for the prevention and/or treatment of sea lice infestation in salmon.
    Type: Application
    Filed: August 16, 2017
    Publication date: June 6, 2019
    Inventors: Jose de Jesus de la Fuente Garcia, Marinela Contreras Rojo, Margarita Maria Villar Rayo, Marius Andre De Feijter Karlsen, Bjorn Erik Brudeseth, Karine Lindmo Yttredal, Christer Ross Wiik-Nielsen, Rolf Hetlelid Olsen, Liv Blom Hungerholdt